LDF Files Amicus Brief in Case Regarding FDA Approval of Mifepristone
April 13, 2023
April 13, 2023
NEW YORK, April 13 (TNSgov) -- The NAACP Legal Defense and Educational Fund issued the following news:
On Tuesday, the Legal Defense Fund (LDF) filed an amicus brief in the United States Court of Appeals for the Fifth Circuit in Alliance for Hippocratic Medicine v. FDA, a case regarding the U.S. Food and Drug Administration's (FDA) approval of mifepristone.
Last Friday, a federal judge in Texas issued an unprecedented opinion that could effectively ban the sale of mifep . . .
On Tuesday, the Legal Defense Fund (LDF) filed an amicus brief in the United States Court of Appeals for the Fifth Circuit in Alliance for Hippocratic Medicine v. FDA, a case regarding the U.S. Food and Drug Administration's (FDA) approval of mifepristone.
Last Friday, a federal judge in Texas issued an unprecedented opinion that could effectively ban the sale of mifep . . .